Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rocket Pharmaceuticals
Biotech
Fierce Biotech's 10 most-read stories of 2025
Trackers aside, the clinical hold on Rocket’s pivotal gene therapy trial after a patient death was the top-read story of 2025.
Gabrielle Masson
Dec 29, 2025 7:00am
Rocket aborts mission to get rare disease gene therapy approved
Oct 3, 2025 9:30am
Rocket's gene therapy free from FDA hold
Aug 20, 2025 10:40am
Rocket adjusts trajectory, laying off staff and narrowing focus
Jul 24, 2025 8:05am
Rocket crashes as gene therapy patient dies, FDA imposes hold
May 27, 2025 9:49am
Rocket's gene therapy sets new efficacy bar in ph. 1 heart study
May 16, 2025 10:36am